| Product Code: ETC7378224 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a decline in growth rate from 2023 to 2024, Grenada`s import of pneumococcal polysaccharide vaccine continued to show promising growth with a CAGR of 12.04% from 2020 to 2024. The top exporting countries to Grenada in 2024 were Trinidad and Tobago, USA, UK, Barbados, and India, indicating a diverse source of imports. However, the high Herfindahl-Hirschman Index (HHI) suggests a concentrated market, highlighting potential challenges in ensuring competitive pricing and supply stability in the future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Pneumococcal Polysaccharide Vaccine Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Pneumococcal Polysaccharide Vaccine Market - Industry Life Cycle |
3.4 Grenada Pneumococcal Polysaccharide Vaccine Market - Porter's Five Forces |
3.5 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.6 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Grenada Pneumococcal Polysaccharide Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Grenada |
4.2.2 Government initiatives to improve healthcare infrastructure and access to vaccines |
4.2.3 Growing prevalence of pneumococcal diseases in the region |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal polysaccharide vaccine |
4.3.2 Limited healthcare budget in Grenada |
4.3.3 Lack of healthcare professionals trained in administering vaccines |
5 Grenada Pneumococcal Polysaccharide Vaccine Market Trends |
6 Grenada Pneumococcal Polysaccharide Vaccine Market, By Types |
6.1 Grenada Pneumococcal Polysaccharide Vaccine Market, By Dosage |
6.1.1 Overview and Analysis |
6.1.2 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Dosage, 2021- 2031F |
6.1.3 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Single Dose Vial, 2021- 2031F |
6.1.4 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Pre-Filled Syringe, 2021- 2031F |
6.2 Grenada Pneumococcal Polysaccharide Vaccine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Children (2-10 Age), 2021- 2031F |
6.2.3 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Adult (10-64 Age), 2021- 2031F |
6.2.4 Grenada Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Geriatric (More Than 65 Age), 2021- 2031F |
7 Grenada Pneumococcal Polysaccharide Vaccine Market Import-Export Trade Statistics |
7.1 Grenada Pneumococcal Polysaccharide Vaccine Market Export to Major Countries |
7.2 Grenada Pneumococcal Polysaccharide Vaccine Market Imports from Major Countries |
8 Grenada Pneumococcal Polysaccharide Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Grenada |
8.2 Number of government-funded vaccination programs implemented |
8.3 Rate of reported pneumococcal disease cases in Grenada |
8.4 Number of healthcare professionals trained in administering pneumococcal vaccines |
8.5 Average waiting time for individuals to receive pneumococcal vaccination in Grenada |
9 Grenada Pneumococcal Polysaccharide Vaccine Market - Opportunity Assessment |
9.1 Grenada Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.2 Grenada Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Grenada Pneumococcal Polysaccharide Vaccine Market - Competitive Landscape |
10.1 Grenada Pneumococcal Polysaccharide Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Grenada Pneumococcal Polysaccharide Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here